Skip to main content

Table 1 Patient characteristics and HIV-1 variants

From: High prevalence of HIV-1 drug resistance among patients on first-line antiretroviral treatment in Lomé, Togo

Characteristic

Patients (n = 188) Number (%)

Age, median years

37 (IQR 32-43)

Male sex

66 (35.1)

Treatment interruption (days)

 

   [1-30]

82 (43.6)

   >30

22 (11.7)

   Total

104 (55.3)

CD4 lymphocyte at enrolment (n = 160)

 

CD4 count, median cells/mm3

100 (IQR 54-173)

CD4 lymphocyte at end point (n = 160)

 

CD4 count, median cells/mm3

293 (IQR 188-431)

Viral load at end point ≥1000 copies/ml

58 (30.9)

Genotypic drug-resistance mutations

46 (24.5)

HIV subtypes/CRFs

 

   CRF02

26

   CRF06

6

   G

1

   Unique recombinant formsa

13

  1. a.The following unique recombinant forms were observed: CRF02/A3 (n = 2), CRF02/CRF06 (n = 1), CRF02/U (n = 2), G/A (n = 1), G/A3 (n = 1), G/A/CRF02 (n = 1), G/CRF06 (n = 1), G/CRF02 (n = 2), CRF02/CRF06/U (n = 1), J/K/U (n = 1); U = Unknown subtype/CRF